Analysts: U.S. CRO market to grow 9.7% by 2015; In clinical trials, some patients remain unaware of serious side effects;

> The U.S. CRO market will grow about 9.7% by 2015, Research and Markets reports, facing the challenges of mounting outsourcing and a shortage of staff. Release

> Some post-market clinical trials carry significant risk of serious side effects, and, in many cases, physicians aren't required to inform patients. Story

> Bend Research has opened a spray-drying facility, allowing it to work with high-potency ingredients and manufacture APIs for inhaled delivery. News

> Precos got a license to store and handle tissue from the U.K.'s Human Tissue Authority, allowing the company to expand its portfolio of preclinical cancer models. Article

> The European Medicines Agency has recalled a drug manufactured by Pacira ($PCRX) in California, saying it has discovered sterility issues at the company's plant. More

Suggested Articles

Dubbed “Project Nightingale,” the efforts were announced amid concerns and federal inquiries into the data’s safekeeping and patient consent for use.

Independent site management organization Panthera Biopartners has kick-started its first clinical trial in the U.K.

WIRB-Copernicus Group’s clinical services division bought out trial consultancy firm Waife & Associates as it looks to boost its management services.